Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials.
Saved in:
| Title: | Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials. |
|---|---|
| Authors: | de Moraes, Francisco Cezar Aquino1 (AUTHOR) francisco.cezar2205@gmail.com, Pasqualotto, Eric2 (AUTHOR), Chavez, Matheus Pedrotti2 (AUTHOR), Ferreira, Rafael Oliva Morgado2 (AUTHOR), De Castria, Tiago Biachi3,4 (AUTHOR), Burbano, Rommel Mario Rodríguez5 (AUTHOR) |
| Source: | BMC Cancer. 2/21/2024, Vol. 24 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-024-11980-w |
